Goralatide acetate

• CAT Number: I043920
• Molecular Formula: C22H37N5O11
• Molecular Weight: 547.56
• Purity: ≥95%
• Synonyms: (2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carboxylic acid;acetic acid
• InChI: InChI=1S/C20H33N5O9.C2H4O2/c1-11(27)22-14(10-26)18(31)24-13(9-16(28)29)17(30)23-12(5-2-3-7-21)19(32)25-8-4-6-15(25)20(33)34;1-2(3)4/h12-15,26H,2-10,21H2,1H3,(H,22,27)(H,23,30)(H,24,31)(H,28,29)(H,33,34);1H3,(H,3,4)/t12-,13-,14-,15-;/m0./s1
• InChIKey: IYSLFKMYLHUWSA-WFGXUCIJSA-N
• SMILES: CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O.CC(=O)O

Goralatide acetate（Cat No.:I043920）is a synthetic peptide compound being investigated for its potential therapeutic applications, particularly in the fields of oncology and regenerative medicine. It is designed to target specific receptors involved in cell signaling, with the aim of modulating biological processes like cell proliferation, differentiation, and apoptosis. Goralatide acetate has shown promise in preclinical studies for its ability to influence tissue repair and cancer cell growth. Ongoing research aims to evaluate its efficacy in treating conditions such as cancer, fibrosis, and tissue damage, with a focus on safety and clinical applicability.